Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
Digital will spark integrated development approaches and introduce successful adjunctive therapies for disease modification
save 10 %
* Required Fields
Pay by invoice
As we live longer, we need to increasingly battle age-related disorders, with neurodegenerative disorders the most worrisome because they impact millions of people around the world but lack any curative therapy. While companies continue their search for the holy grail they are also battling the declining revenues from marketed products used to manage symptoms. Heavy genericization followed by price erosion, reliance on patient-reported data for diagnosis and measuring outcomes and elusive R&D success has put unprecedented pressure on pharma companies and prompted several to shed their assets mid-way. This research service in addition to quantifying current market provides details of future products and expected revenue generation from them. While the therapy market is marred by high rates of pipeline attrition there are several parallel areas of growth. For instance, the study covers regenerative medicine, which has grown by leaps and bounds and offers the promise of curative therapies on the horizon. The study also dives deeper into different technological advancements, geographical trends and potential partnership opportunities for Alzheimer’s as well as Parkinson’s Disease. The study covers opportunities in prevention facilitated by digital solutions integration in conjunction with understanding disease diagnosis and progression, in expediting drug development and most importantly in delivering the required outcome to the patient. Additionally, the study captures the competitive landscape, different strategies employed by companies to stay ahead of the curve and identifies game-changing companies leading innovation from the front. Acknowledging the high cost of failure, the research service investigates the need and growing acceptance of open innovation to curate data, ask better questions, extract meaningful insights, and create a more accurate and predictable solution. In addition to collaboration with peers, the companies will seek partnership with digital partners. Given the growing availability of data, technologies and tools, and research expertise there are several companies seeking clinically-validated solutions and have been profiled in the study. The study lays down strategic imperatives for companies to recalibrate their business models based on collaboration and be future ready. Information is also given on some of the leading M&A activities impacting the market as well as unconventional collaboration agreements laying the foundation for propelling innovations toward licensure and delivery. Furthermore, present and future market trends like regulatory support, focus on wellness and wellbeing and value chain convergence, which would shape the market, are discussed. Some of the key questions answered by this study include: 1 What are the total market size and projected growth of global neurodegenerative therapeutics? Which are the largest growth segments to be pursued? 2) How are the various regions around the globe positioned to monetize the market opportunities? What are the key regional barriers to entry? 3) Which are the new risk mitigation strategies and alternative big bets to circumvent the current R&D challenges? Which partnership models are lucrative in the long-term? 4) What are the market-defining macro trends mandating the need to deploy new digital therapeutic solutions to enable centric care in a variety of settings? 5) What is the implication of emerging technologies and digital transformation on the overall market? How is it expected to impact the market in the near-term? 6) Which are the key game-changing companies in the segment and how are they riding the growth curve?
cyber security market
digital signage market
renewable energy market
natural gas market
solar panel market
diabetes devices market
mobile biometrics market
Fill in the fields below to receive a sample report
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.